The Open University - Medicating the bottom billion

April 9, 2009

The Open University played host to a debate about the huge sums spent on the fight against Aids and other killer conditions in developing countries. Discussion at the two-day meeting in Milton Keynes revolved around integrating foreign investment into healthcare and drug production in the world's poorest countries. Joanna Chataway, co-director of the Innogen Centre, which investigates shared ground in the fields of biotechnology and genomics, said the funding balance was not yet right. "In developing new drugs, there is a need to resolve capacity within developing countries so that they not only have access to these medicines, but they are capable of contributing to the production and distribution of them," she said.

Please login or register to read this article.

Register to continue

Get a month's unlimited access to THE content online. Just register and complete your career summary.

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments

Have your say

Log in or register to post comments